The study of PTEN-/TP53- mouse model of primary prostate cancer cells and tumor xenografts allowed to show that hexokinase 2-medaited aerobic glycolysis is required for PTEN-/TP53-deficiency-driven tumor growth [251]. This evidence concerns the gene TP53 and prostate carcinoma.